They have got themselves in the BP’s eyes from an early stage.
Also, the Lilly deal is means Aktis does the preclinical and Lilly will take over from phase 1. Is Lilly acting desperate?
CU6 - Media and Industry News, page-134
-
- There are more pages in this discussion • 256 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.62 |
Change
-0.180(0.00%) |
Mkt cap ! $1.817B | |||
| Open | High | Low | Value | Volume |
| $5.89 | $6.10 | $5.54 | $0 | 820.4K |
| CU6 (ASX) Chart |